Dr. Thomas W. Samuelson shares his experiences with the new iStent inject. Sightpath Medical and Glaukos are pleased to present this recorded webinar from October 11, 2018, on how to offer this exciting new technology to your patients.
If you have any questions about how to access the iStent inject with your Sightpath service, please contact us.
A research team composed of scientists from the Philippines, United Kingdom, and the United States found that – compared to manual clear corneal incisions (CCI) – femtosecond laser-constructed incisions achieve better wound sealability, a quality that may reduce the risk of surgical complications.
Sightpath Medical will be at the ASCRS Annual Meeting in Boston, MA, May 15 – 19, 2020. Here at Sightpath, we believe eye care providers deserve access to affordable, state-of-the-art technologies and highly qualified certified technologists regardless of location.
Ross is one of the many wonderful MoFe engineers at Sightpath Medical. What does he have to say about it?